Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

MeVis Medical Solutions (M3V) Stock Price & Analysis

M3V Stock Chart & Stats

€20.40€0.20(0.99%)
At close: 5:30 PM GMT+1
EUR 20EUR 22EUR 2431 Jul17 Aug31 Aug16 Sep28 Sep12 Oct26 Oct
Day’s Range
EUR 20.20 - EUR 20.40
52-Week Range
EUR 19.90 - EUR 26.80
Previous Close
EUR 20.20
Volume
1
Average Volume (3M)
63
Market Cap
EUR 37.13M
Enterprise Value
EUR 39.30T
Total Cash (Recent Filing)
EUR 3.65M
Total Debt (Recent Filing)
EUR 0
Price to Earnings (P/E)
26.8
Beta
0.17
Next Earnings
Jan 28, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Mar 20, 2026
Dividend Yield
4.66%

Bulls Say, Bears Say

Bulls Say

Debt-free Balance Sheet

The absence of total debt gives MeVis Medical Solutions a conservative capital structure and reduces exposure to interest costs, refinancing pressure, and lender constraints. Stable equity further supports financial resilience and preserves flexibility to fund operations or strategic initiatives.

High-margin Business Model

Consistently strong gross, operating, and net margins indicate that the software-oriented business model retains substantial value from its revenue. This profitability provides internal funding capacity and can help sustain investment even while the company addresses slower growth.

Generally Strong Cash Generation

Free cash flow that usually tracks net income suggests reported profitability is generally supported by cash generation rather than being purely accounting-based. This strengthens the company’s ability to finance operations, maintain distributions, and pursue opportunities without relying on debt.

Bears Say

Multi-year Revenue Decline

Three consecutive annual revenue declines point to a persistent weakening in the company’s top-line trajectory rather than a single-period fluctuation. Continued contraction could limit operating leverage, reduce reinvestment capacity, and make it harder to sustain historical profitability over the next several quarters.

Reduced Profitability From Peak

The substantial reduction in net margin from the 2022 peak shows that MeVis is converting less revenue into earnings than it did previously. If profitability remains below historical levels, earnings power, return potential, and the resources available for product development or shareholder distributions may remain constrained.

Uneven Cash-flow Conversion

Although cash generation is generally good, the wide variation in operating-cash-flow conversion and sharp free-cash-flow declines in some years make financial performance less predictable. This variability can complicate planning and reduce confidence that reported earnings will translate consistently into deployable cash.

M3V FAQ

What was MeVis Medical Solutions’s price range in the past 12 months?
MeVis Medical Solutions lowest stock price was €19.90 and its highest was €26.80 in the past 12 months.
What is MeVis Medical Solutions’s market cap?
MeVis Medical Solutions’s market cap is €37.13M.
When is MeVis Medical Solutions’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MeVis Medical Solutions’s earnings last quarter?
MeVis Medical Solutions released its earnings results on May 21, 2026. The company reported €0.342 earnings per share for the quarter.
Is MeVis Medical Solutions overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does MeVis Medical Solutions pay dividends?
MeVis Medical Solutions pays a Annually dividend of €0.95 which represents an annual dividend yield of 4.66%. See more information on MeVis Medical Solutions dividends here
What is MeVis Medical Solutions’s EPS estimate?
MeVis Medical Solutions’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MeVis Medical Solutions have?
MeVis Medical Solutions has 1,820,000 shares outstanding.
What happened to MeVis Medical Solutions’s price movement after its last earnings report?
MeVis Medical Solutions reported an EPS of €0.342 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of MeVis Medical Solutions?
Currently, no hedge funds are holding shares in DE:M3V
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology